Exhibit 99.1 February 17, 2005 FOR: FOR IMMEDIATE RELEASE MEDTOX SCIENTIFIC FILES 510(K) APPLICATION WITH FDA FOR ITS NEW |
MEDTOX Scientific, Inc. The Company is currently unaware of any existing FDA cleared POCT devices with this broad panel and low detection levels. MEDTOX Scientifics’ unique structure in owning an ISO certified POCT device manufacturer and a federally certified drug screening laboratory creates additional competitive advantages in two ways. First, Sure-Screen® is a preliminary on-site screen that may require further laboratory confirmation. MEDTOX’s laboratory can provide that confirmation in a seamless manner. Second, there are a limited number of laboratories that are either willing or capable of confirming the low drug levels that will be detected by Sure-Screen®. MEDTOX Scientific, Inc., headquartered in St. Paul, Minn., is a provider of high quality specialized laboratory and on-site/point-of-collection (POC) devices. The Company also supports customers with complete logistics, data and program management services. MEDTOX develops and manufactures diagnostic devices for quick and economical on-site/point-of-collection analysis for drugs-of-abuse, therapeutic drugs and biological and agricultural toxins and provides employment drug screening and occupational health testing. MEDTOX is a leader in providing esoteric laboratory testing services to hospitals and laboratories nationwide. This includes both central laboratory and bio-analytical testing for pharmaceutical clinical trials. For more information seewww.medtox.com. |